Related Experiment Video
Updated: Mar 17, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Pathogen-induced secretory diarrhea and its prevention
1TFSL, Dairy Microbiology Division, ICAR- National Dairy Research Institute, Karnal, Haryana, India.
Secretory diarrhea, caused by pathogens, disrupts intestinal fluid balance. New antisecretory agents offer promising therapeutic options for this global health issue.
Area of Science:
- Microbiology
- Gastroenterology
- Pharmacology
Background:
- Secretory diarrhea is a significant global health concern, primarily caused by pathogenic microorganisms.
- It disrupts intestinal fluid and ion transport, affecting epithelial cell functions.
Purpose of the Study:
- To review the infective mechanisms of non-inflammatory secretory diarrhea pathogens.
- To discuss current and emerging therapeutic strategies for secretory diarrhea.
Main Methods:
- Literature review of pathogenic mechanisms and therapeutic interventions for secretory diarrhea.
- Analysis of the efficacy of antibacterial drugs, vaccines, nutritional therapy, probiotics, prebiotics, and novel antisecretory agents.
Main Results:
- Pathogens breach cell barriers and alter ion transport via CFTR and calcium-activated chloride channels.
- Current therapies include antibiotics, vaccines, and supportive care; newer agents target intestinal fluid secretion mechanisms.
Conclusions:
- Understanding molecular targets in intestinal fluid secretion is crucial for developing effective therapies.
- The development of novel antisecretory agents shows promise in reducing the burden of diarrheal diseases.
More Related Videos
10:59Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens
Published on: May 12, 2019
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...